Search clinical trials for: Iron Isomaltoside 1000

Total 3408 results

Pharmacosmos A/S

Completed

Open-label Pharmacokinetic Study of Iron Isomaltoside 1000 (Monofer®) Administered by 500 mg IV Bolus Injection or 1000 mg Intravenous Infusion to Patients With Non-hematological Malignancies Associated With Chemotherapy Induced Anaemia (CIA) (PK-CIA-04)

Non-hematological Malignancies
Pharmacosmos A/S

Completed

Iron Isomaltoside 1000 (Monofer®) Administered by a High Dosing Regimen in Subjects With Inflammatory Bowel Disease (IBD-02)

Inflammatory Bowel Disease

Denmark
Seoul National University Hospital

Completed

Effect of IV Iron Isomaltoside on Postoperative Anemia in Total Knee Arthroplasty Patients

Anemia | Knee Arthropathy

Korea, Republic of
Pharmacosmos A/S

Completed

Pharmacokinetic Study of Iron Isomaltoside 1000 Administered by 250 mg IV Bolus Injection or 500 mg Intravenous Infusion to Patients With Non-hematological Malignancies Associated With Chemotherapy Induced Anaemia (PK-CIA-06)

Patients With Chemotherapy Induced Anemia (CIA)

United States
University of Malaya

Recruiting

Single Dose Intravenous Iron Isomaltoside in Combination With Oral Iron vs Oral Iron Monotherapy in Patients With Anemia After Postpartum Haemorrhage (IVIronPPH)

Anemia | Post Partum Hemorrhage

Malaysia
Pharmacosmos A/S
BioStata

Completed

A Non-interventional Study of Diafer in Subjects With CKD on Haemodialysis for Treatment of Iron Deficiency (DINO)

Anaemia in Chronic Kidney Disease

Sweden, United Kingdom
Pharmacosmos UK Ltd
BioStata

Completed

Time to Relapse of Iron Deficiency Anaemia After Standard Treatment With The Intravenous Iron (Monofer®)

Iron Deficiency Anaemia

United Kingdom
Pharmacosmos A/S
BioStata

Completed

Time to Relapse of Iron Deficiency Anemia After Standard Treatment With a New Intravenous Iron (Monofer®)

Iron Deficiency Anemia

Denmark
Pharmacosmos A/S

Completed

Dose-escalation Trial of the Safety, Pharmacokinetics, and Pharmacodynamics of Iron Isomaltoside (Monofer®)

Anemia | Iron Metabolism Disorders | Deficiency Diseases | Anemia, Iron Deficiency | Hematologic Disease

Japan
Pharmacosmos A/S

Completed

Open-label PK Study of Iron Isomaltoside 1000 (Monofer) Administered by 500 mg IV Injection or 1000 mg IV Infusion to Patients With Inflammatory Bowel Disease

Inflammatory Bowel Disease
Ain Shams University

Completed

Effect of Intravenous Iron Supplementation in Reducing Allogenic Blood Transfusion

Complications

Egypt
Universität des Saarlandes

Completed

A Study Comparing the Iron Substitution With the Medicinal Products Ferinject or Monofer (HOMe_aFers_1)

Anemia, Iron-Deficiency

Germany
Sun Yat-sen University

Recruiting

Iron Isomaltide for Iron-deficiency Anemia Patients With Locally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma | Iron-deficiency | Anemia

China
Yonsei University

Completed

Effect of Perioperative Iron Isomaltoside 1000 Administration on Transfusion Requirements in Patients Undergoing Complex Valvular Heart Surgery: a Randomized Clinical Trial

Complex Valvular Heart Surgery

Korea, Republic of
Pharmacosmos A/S
Max Neeman

Completed

A Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Administered by Infusions to Iron-deficient Blood Donors

Iron-deficiency

Denmark
Pharmacosmos A/S

Completed

A Trial Comparing the Incidence of Hypophosphatemia in Relation to Treatment With Iron Isomaltoside and Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia Due to Inflammatory Bowel Disease

IBD

Denmark
Yonsei University

Unknown

Efficacy of Intravenous Iron Therapy in Maintaining Hemoglobin Concentration on Patients Undergoing Bimaxillary Orthognathic Surgery

Facial Asymmetry | Prognathism | Retrognathism

Korea, Republic of
Lucie Favre

Not yet recruiting

IV Iron-induced Hypophosphatemia After RYGB (IVORY)

Roux-en-Y Gastric Bypass | Hypophosphatemia
Oslo University Hospital
Pharmacosmos A/S

Completed

Intravenous Iron Supplement for Iron Deficiency in Cardiac Transplant Recipients (IronIC)

Heart Transplant Recipients

Norway
Pharmacosmos A/S

Completed

A Study of Intravenous Iron Isomaltoside 1000 (Monofer®) as Mono Therapy (Without Erythropoiesis Stimulating Agents) in Comparison With Oral Iron Sulfate in Subjects With Non-myeloid Malignancies Associated With Chemotherapy Induced Anaemia (CIA)

Non-myeloid Malignancies | Chemotherapy Induced Anaemia

India
Pharmacosmos A/S
CRO Max Neeman

Completed

A Prospective, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Administered by Infusions to Non-Anaemic Patients Undergoing Elective or Sub-Acute Coronary Artery Bypass Graft, Valve Replacement or a Combination Thereof (CABG-01)

Non-anaemic Patients Undergoing Cardiac Surgery

Denmark
Alberta Health Services, Calgary
Pharmacosmos A/S

Not yet recruiting

Ferric Derisomaltose/Iron Isomaltoside and Outcomes in the Recovery of Gynecologic Oncology ERAS (FORGE)

Gynecologic Cancer | Surgery | Anemia, Iron Deficiency
Bayside Health
National Health and Medical Research Council, Australia; Monash University

Recruiting

Intravenous Iron for Treatment of Anaemia Before Cardiac Surgery (ITACS)

Anaemia

Australia
Michael Kremke
Aarhus University Hospital; Pharmacosmos A/S; University of Aarhus

Completed

A Clinical Trial Assessing the Efficacy of Intravenous Iron for the Treatment of Anemia Following Cardiac Surgery (PICS)

Anemia Postoperative

Denmark
Pharmacosmos A/S
Laboratory Corporation of America; BioStata; ClinStar, LLC

Completed

IDA-01 A Randomised, Open-Label, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) and Iron Sucrose (Provide)

Iron Deficiency Anaemia

United States
Yonsei University

Recruiting

Effect of Preoperative Iron Isomaltoside 1000 Administration on Hemoglobin Concentration in Patients Undergoing Transcatheter Aortic Valve Implantation

Aortic Stenosis (Treated With TAVI)

Korea, Republic of
Prince of Wales Hospital, Shatin, Hong Kong

Completed

Efficacy of Preoperative Intravenous Iron in Anaemic Colorectal Cancer Surgical Patients

Anemia, Iron-Deficiency | Colorectal Cancer

Hong Kong
University Medical Centre Ljubljana

Completed

Intravenous Iron Carboxymaltose, Isomaltoside and Oral Iron Sulphate for Postpartum Anemia

Iron-deficiency | Postpartum Anemia Nos

Slovenia
Oslo University Hospital

Active, not recruiting

Intravenous Iron Supplement for Iron Deficiency in Patients With Severe Aortic Stenosis (IIISAS)

Iron-deficiency | Severe Aortic Stenosis

Norway
Kaunas University of Medicine
Pharmacosmos A/S; Orivas, Lithuania

Unknown

Intravenous Iron for Correction of Anaemia After Colorectal Surgery

Colorectal Neoplasms | Anemia, Iron-Deficiency | Colorectal Surgery | Intravenous Drug Usage

Lithuania
Saskatchewan Health Authority - Regina Area
Saskatchewan Centre for Patient-Oriented Research

Recruiting

Ferric Derisomaltose (Iron Isomaltoside) Versus Iron Sucrose for Treatment of Iron Deficiency in Pregnancy

Iron Deficiency Anaemia in Childbirth

Canada
University Hospital, Angers

Terminated

HiFIT Study : Hip Fracture: Iron and Tranexamic Acid (HiFIT)

Anemia | Hip Fractures Pathologic

France
Yonsei University

Unknown

Intravenous Iron Isomaltoside 1000 (Monofer®) Compared With Oral Iron in the Treatment of Postgastrectomy Anemia: An Open-label Randomized Controlled Trial

Post Gastrectomy Anemia

Korea, Republic of
Pharmacosmos A/S

Completed

An Extension Trial to Assess the Safety of Re-dosing of Iron Isomaltoside/Ferric Derisomaltose (Monofer®/Monoferric®) (FERWON-EXT)

Iron Deficiency Anemia | Iron Deficiency Anaemia

United States
Nottingham University Hospitals NHS Trust
Pharmacosmos A/S

Unknown

Iron Replacement in Oesophagogastric Neoplasia (IRON)

Anemia | Gastric Cancer | Esophageal Cancer

United Kingdom
The University of Hong Kong

Terminated

Iron Isomaltoside Compared With Iron Sucrosein Peritoneal Dialysis Patients

Iron Deficiency Anemia Treatment

Hong Kong
Thomas Jefferson University
Jawaharlal Nehru Medical College

Active, not recruiting

Neuroimaging Ancillary Study

Iron Deficiency Anemia | Child Development | Iron Deficiency Anemia of Pregnancy | Iron Deficiency Anemia Treatment | Neurodevelopmental Disorder of Foetus | Fetal Neurodevelopmental Disorder

India
Pharmacosmos A/S

Withdrawn

A Randomized, Double-blind, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Against Placebo

Iron Deficiency Anemia

United States
Pierre Fabre Pharma AG

Completed

Real Life Study on Iron Isomaltoside 1000 in the Treatment of ID in CKD, Heart Failure, ObGyn, IBD, Cancer and Elective Surgery (Real-CHOICE). (Real-CHOICE)

Iron-Deficiency Anemia | Iron-Deficiency

Switzerland
Thomas Jefferson University
Jawaharlal Nehru Medical College; Children's Investment Fund Foundation; S. Nijalingappa... and other collaborators

Completed

Reducing Anemia in Pregnancy in India: the RAPIDIRON Trial (RAPIDIRON)

Iron Deficiency Anemia | Infant, Low Birth Weight | Anemia of Pregnancy

India
Thomas Jefferson University
Jawaharlal Nehru Medical College; S. Nijalingappa Medical College; Raichur Institute...

Active, not recruiting

RAPIDIRON Trial Follow-up Study: RAPIDIRON-KIDS Study (RAPIDIRON-KIDS)

Autism Spectrum Disorder | Iron Deficiency Anemia | Neurodevelopmental Abnormality

India
Pharmacosmos A/S
Laboratory Corporation of America; BioStata

Withdrawn

IV Iron Treatment of Restless Legs Syndrome

Restless Legs Syndrome
University of Saskatchewan

Not yet recruiting

Effect of Intravenously Iron Infusion on the Prevention and Treatment of Anemia in Ovarian Cancer

Anaemia in Ovarian Carcinoma

Canada
Pharmacosmos A/S

Completed

Open-label Pharmacokinetic Study of Iron Isomaltoside 1000 (Monofer®) Administered by 500 mg IV Bolus Injection or 1000 mg Intravenous to Patients With CKD (PK-CKD-03)

Non-dialysis Dependent Chronic Kidney Disease
Pharmacosmos A/S

Completed

Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose vs Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia

Iron Deficiency Anemia | Iron Deficiency Anaemia

United States
Pharmacosmos A/S

Completed

Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose or Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia

Iron Deficiency Anemia | Iron Deficiency Anaemia

United States
Pharmacosmos A/S

Completed

Intravenous Iron Isomaltoside Versus Oral Iron Supplementation for Treatment of Iron Deficiency in Pregnancy.

Iron Deficiency Anemia of Pregnancy

Denmark
Pharmacosmos A/S

Completed

Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA)

Iron Deficiency Anemia | Iron Deficiency Anaemia

United States
Pharmacosmos A/S

Completed

Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for Treatment of Iron Deficiency Anemia in Non-Dialysis-Dependent Chronic Kidney Disease

Chronic Kidney Disease | Iron Deficiency Anemia | Iron Deficiency Anaemia

United States
Pharmacosmos A/S
BioStata

Completed

Treatment of Women After Severe Postpartum Haemorrhage (PP-02)

Severe Postpartum Haemorrhage

Denmark

3

Subscribe